Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned

Nine out of ten metastatic prostate cancer (PCa) patients will develop osseous metastases. Of these, every second will suffer from skeletal-related events (SRE). SRE are associated with an increased risk for death, which is markedly increased in the presence of pathological fracture. Moreover, healt...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Christian, Bartsch, Georg, Walter, Christian, Borgmann, Hendrik, Brandt, Maximilian Peter, Höfner, Thomas, Haferkamp, Axel, Tsaur, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806937/
https://www.ncbi.nlm.nih.gov/pubmed/29563470
http://dx.doi.org/10.3390/dj4030028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806937/
https://www.ncbi.nlm.nih.gov/pubmed/29563470
http://dx.doi.org/10.3390/dj4030028

Ejemplares similares